yourstate.us
21 CFR 522.1290

§ 522.1290 Luprostiol.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 522.1290, § 522.1290 Luprostiol, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87477
Permanent ID
ys:prov:87477@1
SHA-256
b682beee6b2f799629129bdd7327fcad72b1e54f14676ec2060793560c844314

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains 7.5 milligrams (mg) luprostiol. (b) Sponsor. See No. 051311 in § 510.600(c) of this chapter. (c) Special considerations. Labeling shall bear the following statements: Warning: Women of childbearing age, asthmatics, and persons with bronchial and other respiratory problems should exercise extreme caution when handling this product. In the early stages, women may be unaware of their pregnancies. Luprostiol is readily absorbed through the skin and can cause abortion and/or bronchiospasms. Direct contact with the skin should therefore be avoided. Accidental spillage on the skin should be washed off immediately with soap and water. (d) Conditions of use in horses—(1) Amount. 7.5 mg by intramuscular injection. (2) Indications for use. For estrus control and termination of pregnancy in mares. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.